Rankings
▼
Calendar
BDX Q2 2025 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena
BDX
Becton, Dickinson and Company
$60B
Q2 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$5.3B
+4.5% YoY
Gross Profit
$2.3B
42.8% margin
Operating Income
$546M
10.4% margin
Net Income
$308M
5.8% margin
EPS (Diluted)
$1.07
QoQ Revenue Growth
+2.0%
Cash Flow
Operating Cash Flow
$164M
Free Cash Flow
$35M
Stock-Based Comp.
$149M
Balance Sheet
Total Assets
$54.5B
Total Liabilities
$29.2B
Stockholders' Equity
$25.2B
Cash & Equivalents
$667M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.3B
$5.0B
+4.5%
Gross Profit
$2.3B
$2.3B
-2.0%
Operating Income
$546M
$734M
-25.6%
Net Income
$308M
$537M
-42.6%
Revenue Segments
Medical
$2.8B
52%
Interventional
$1.3B
24%
Life Sciences
$1.2B
24%
Geographic Segments
UNITED STATES
$3.1B
59%
Non-US
$2.2B
41%
← FY 2025
All Quarters
Q3 2025 →